FDA Is Rethinking Rare Disease Review. CMC Readiness Cannot Wait.
The FDA’s new Rare Disease Framework Initiative could reshape regulatory review, but manufacturing readiness remains critical. Discover why CMC planning, qualification, validation, and cross-functional coordination are essential for pharmaceutical and biotechnology manufacturers navigating evolving regulatory expectations.
Robotic Medical Devices Are Advancing, but Submission Readiness Will Decide What Moves Forward
Robotic medical devices are getting more regulatory attention, and that should matter to every team working in…
Plasmid DNA Supply Is Becoming the New Readiness Test for Cell and Gene Therapy
Cell and gene therapy developers are moving quickly, but one of the most important execution issues is…
NGS Testing for Biologics Is Becoming a Readiness Issue, Not Just a Science Issue
Biologics manufacturers are facing a familiar challenge in a new form: the science is advancing, but execution…
Sterile Fill-Finish Transfers Are Rising, and Site Readiness Is the Real Test
Sterile injectable manufacturing is getting more attention, but the real story is not simply that companies are…
As Pharma Leans on CDMOs, Tech Transfer Readiness Becomes the Real Risk
Pharmaceutical companies are continuing to rely on external manufacturing partners, but the bigger issue is no longer…
FDA’s New Cell and Gene Therapy Guidance Puts CMC Readiness Back in Focus
Cell and gene therapy is moving quickly, but the latest FDA activity is a reminder that promising…
Paperless Validation Is Not a Software Project
Digital validation is becoming a major priority across life sciences, but the mistake many teams make is…
Life Sciences M&A Is Back in the Headlines, but Integration Is Where the Real Work Begins
Life sciences manufacturing investment continues to move quickly. Bristol Myers Squibb announced that it selected Generation Park…
Domestic Pharma Manufacturing Is Growing, but Execution Will Decide What Actually Comes Online
Domestic pharmaceutical manufacturing is moving from a policy conversation to a project execution challenge. In recent weeks,…